透明质酸等指标对原发性胆汁性胆管炎患者肝纤维化的预测价值OA
Hyaluronic Acid and Other Indicators for Predicting Liver Fibrosis in Primary Biliary Cholangitis
目的 探讨透明质酸相对正常上限值、凝血酶原时间、免疫球蛋白G及其他血清学指标,在伴有界面性肝炎的原发性胆汁性胆管炎(primary biliary cholangitis,PBC)患者中对进展期肝纤维化的预测价值.方法 选取2017年1月至2025年1月在江南大学附属无锡五院住院,经病理学确诊为伴有界面性肝炎的PBC患者174例为研究对象.根据Scheuer评分系统中的纤维化程度分期分别将患者分为显著肝纤维化组92例,进展期肝纤维化组82例.收集患者透明质酸、层粘连蛋白、Ⅲ型前胶原、Ⅳ型胶原、凝血酶原时间、免疫球蛋白G、免疫球蛋白M、谷氨酰转移酶、碱性磷酸酶等指标.采用正常上限值计算指标的相对正常上限值.组间比较血清学指标差异;多因素Logistic回归分析伴有界面性肝炎的PBC患者显著肝纤维化发展至进展期肝纤维化的影响因素;受试者工作特征曲线(receiver operating characteristic curve,ROC)评价血清血清透明质酸(hyaluronic acid,HA)相对正常上限值(relative upper limit of normal,rULN)、凝血酶原时间(prothrombin time,PT)、免疫球蛋白G(immunoglobulin G,IgG)水平对伴有界面性肝炎的PBC患者显著肝纤维化发展至进展期肝纤维化的诊断价值.结果 显著纤维化组的HA rULN、LN rULN、PCⅢ rULN、Ⅳ-C rULN、PT、AST、IgG均低于进展期纤维化组(Z/P=-7.331/<0.001、-4.568/<0.001、-4.738/<0.001、-5.451/<0.001、-6.216/<0.001、-1.981/<0.048,t/P=-5.299/<0.001).多因素Logistic回归分析结果显示,HA rULN、PT、IgG血清水平升高是伴有界面性肝炎的PBC患者显著纤维化发展至进展期肝纤维化的独立危险因素(P<0.01),分别为[OR(95%CI)=3.436(1.691~6.980)];[OR(95%CI)=2.719(1.538~4.805)];[OR(95%CI)=1.191(1.064~1.333)];血清HA rULN、PT、IgG水平及三者联合诊断伴有界面性肝炎的PBC患者从显著肝纤维化发展至进展期肝纤维化的曲线下面积(Area under the curve,AUC)分别为0.822、0.773、0.711、0.883,联合诊断大于HA rULN单独诊断(Z=-2.505,P=0.012),联合诊断大于PT单独诊断(Z=-3.490,P<0.001),联合诊断大于IgG单独诊断(Z=-4.759,P<0.001).结论 HA rULN、PT、IgG三者联合诊断伴有界面性肝炎的PBC患者显著肝纤维化期发展至进展期,具有一定价值,可在临床推广应用.
Objective The aim of this study was to investigate the predictive value of hyaluronic acid relative upper limit of normal,prothrombin time,immunoglobulin G,and other serological indicators for advanced liver fibrosis in patients with primary bili-ary cholangitis(PBC)with interface hepatitis.Methods A total of 174 patients with histopathologically confirmed primary biliary chol-angitis(PBC)complicated by interface hepatitis were enrolled from the Affiliated Wuxi Fifth Hospital of Jiangnan University between January 2017 and January 2023.According to the Scheuer scoring system,the patients were divided into significant liver fibrosis group(92 cases)and advanced liver fibrosis group(82 cases).Hyaluronic acid,laminin,procollagen type Ⅲ,collagen type Ⅳ,prothrom-bin time,immunoglobulin G,immunoglobulin M,glutamyl transferase,alkaline phosphatase,and other indicators were collected.The relative upper limit of normal of some indicators was calculated using the normal upper limit.Differences in serological indicators between groups were compared.Multivariate Logistic regression analysis was used to analyze the influencing factors of significant liver fibrosis developing to advanced liver fibrosis in PBC patients with interface hepatitis.The receiver operating characteristic curve(ROC)was used to evaluate the diagnostic value of serum HA rULN,PT,and IgG levels for the development of significant liver fibro-sis to advanced liver fibrosis in PBC patients with interface hepatitis.Results The levels of HA rULN,LN rULN,PCⅢ rULN,Ⅳ-C rULN,PT,AST,and IgG were lower in the significant fibrosis group than in the advanced fibrosis group,respectively.(Z/P=-7.331/<0.001、-4.568/<0.001、-4.738/<0.001、-5.451/<0.001、-6.216/<0.001、-1.981/<0.048,t/P=-5.299/<0.001).The results of multifactorial logistic regression analysis showed that elevated serum levels of HA rULN,PT,and IgG were independent risk factors(P<0.01)for significant fibrosis to advanced liver fibrosis in PBC patients with interface hepatitis,respectively.[OR(95%CI)=3.436(1.691~6.980)];[OR(95%CI)=2.719(1.538~4.805)];[OR(95%CI)=1.191(1.064~1.333)].The area under the curve(AUC)for serum HA rULN,PT,IgG levels and the combination of the three for diagnosis of PBC patients with interface hepatitis who progressed from significant liver fibrosis to advanced liver fibrosis were 0.822,0.773,0.711,and 0.883,respectively.The combined diagnosis was greater than that of HA rULN alone(Z=-2.505,P=0.012),the combined diagnosis was greater than that of PT alone(Z=-3.490,P<0.001),and the combined diagnosis was greater than that of IgG alone(Z=-4.759,P<0.001).Conclusion The combined use of HA rULN,PT,and IgG is valuable in diagnosing the development of significant liver fibrosis stage to advanced stage in PBC patients with interface hepatitis.
SUN Lu;LU Zhonghua;XU Chengying;MAO Chengjie;WANG Minying;JU Zhaoxia
Wuxi Clinical College of Nantong University,Wuxi 214000,ChinaDepartment of Hepatology,Affiliated Wuxi Fifth Hospital of Jiangnan University,Wuxi 214000,ChinaDepartment of Hepatology,Affiliated Wuxi Fifth Hospital of Jiangnan University,Wuxi 214000,ChinaWuxi Clinical College of Nantong University,Wuxi 214000,ChinaDepartment of Hepatology,Affiliated Wuxi Fifth Hospital of Jiangnan University,Wuxi 214000,ChinaDepartment of Hepatology,Affiliated Wuxi Fifth Hospital of Jiangnan University,Wuxi 214000,China
医药卫生
界面性肝炎原发性胆汁性胆管炎透明质酸凝血酶原时间免疫球蛋白G肝纤维化
Interface hepatitisPrimary biliary cholangitisHyaluronic acidProthrombin timeImmunoglobulin GLiver fibrosis
《西南医科大学学报》 2026 (1)
39-44,6
评论